Autolus Therapeutics Ltd reported $-59.51M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AstraZeneca USD 7.11B 4.14B Mar/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Novartis USD 4.18B 118M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Silence Therapeutics USD -12.46M 13.78M Dec/2025